China Traditional Chinese Medicine Holdings Co. Limited (SEHK: 570)
Health Care · Pharmaceuticals · HK
HK$1.27
+3.25% today · -47.1% 1Y
China Traditional Chinese Medicine Holdings Co. Limited (SEHK: 570) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $814.96M.
Over the last twelve months the share price has lost 47.1%, trading between 1.16 and 2.68.
Tweenvest scores China Traditional Chinese Medicine Holdings Co. Limited across four factors: quality 69/100, value 70/100, growth 22/100. Its strongest factor is value.
570 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $814.96M
- Revenue (TTM)
- $1.87B
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 0.79
- 52-week high
- HK$2.68
- 52-week low
- HK$1.16
- Avg volume (3M)
- —
- Shares outstanding
- 5.04B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HK inno.N CorporationKOSDAQ: A195940 | $836.59M | ₩39,700.00 | -1.12% |
| SpyGlass Pharma, Inc.NasdaqGS: SGP | $833.52M | $25.08 | +0.64% |
| Hunan Jiudian Pharmaceutical Co., Ltd.SZSE: 300705 | $828.42M | CN¥11.23 | +2.93% |
| Jiangsu Jibeier Pharmaceutical Co., Ltd.SHSE: 688566 | $824.45M | CN¥27.46 | -0.94% |
| Sichuan Goldstone Asia Pharmaceutical Inc.SZSE: 300434 | $807.31M | CN¥13.46 | +4.18% |
| Aarti Pharmalabs LimitedNSEI: AARTIPHARM | $801.57M | Rs855.50 | -11.67% |
| Beijing Beilu Pharmaceutical Co., Ltd.SZSE: 300016 | $795.49M | CN¥9.16 | -4.18% |
| Hubei Biocause Heilen Pharmaceutical Co., Ltd.SZSE: 301211 | $794.91M | CN¥12.75 | +0.39% |
Figures last refreshed Oct 11, 2026.